PhD student in Cancer Research - SK0119

CANBIO is a competitive PhDtraining program for a total of 18 PhD candidates, supported by the researchfunding scheme PRIDE ofthe Luxembourg National Research Fund (FNR). The CANBIO doctoral training unitprovides structured PhD training in cancer biology and aims to bridgefundamental cancer research with clinically-oriented applications
1A-B, rue Thomas Edison, Strassen 1445, Luxembourg
06/02/2019 14:22:52

The research-intensive program tackles next-generation cancer biology covering molecular mechanisms of tumour progression, treatment resistance and biomarker discovery. It focuses on tumour escape mechanisms, thus addressing the increasingly important clinical problem of tumour recurrence and drug resistance. The program includes transferable skill training, support in career development, scientific lectures by international speakers and annual PhD retreats.

The PhD candidate will conduct his/her research project at the Life Sciences Research Unit of the University of Luxembourg (Campus Belval, Esch- sur-Alzette).

He/She will be enrolled at the doctoral school of the University of Luxembourg.

The program will allow the selected candidate to obtain a PhD degree in life sciences  with a focus on melanoma.

View the PhD project summary here

We are seeking an excellent and highly motivated candidate holding a Master’s degree in computational and molecular biology  (MSc or equivalent). Fluency in English is mandatory – it is the working language.

Applications including a motivation letter the contact details of 2 references, a full curriculum vitae and a copy of the relevant diplomas showing marks should be sent before 8 March 2019 through the apply button below only.

Please note that applications failing to contain the requested documents WILL NOT be considered.


4 year fixed-term contract- Full time - Start date : April 2019


More specific information on CANBIO can be obtained from the program coordinator, Prof. Simone Niclou, Head of the NorLux Neuro-Oncology Laboratory at LIH’s Department of Oncology: